Skip to main content
. 2020 Dec 15;22(12):e19452. doi: 10.2196/19452

Table 1.

Baseline characteristics of the intervention and control groups (N=49).

Characteristic All (N=49) Intervention group (n=25) Control group (n=24) P value
Men, n (%) 36 (74) 17 (68) 19 (79) .52
Age (years), mean (SD) 51.22 (10.98) 50.60 (11.87) 51.87 (10.20) .69
Aged ≥65 years, n (%) 4 (8) 3 (12) 1 (4) .48
Education level, n (%)


.02

Elementary school 2 (4) 0 (0) 2 (8)

Junior high school 5 (10) 1 (4) 4 (17)

Senior high school 13 (27) 4 (16) 9 (38)

College or university 29 (59) 20 (80) 9 (38)
Comorbidities, n (%)




Diabetes mellitus 17 (35) 8 (32) 9 (38) .50

Hypertension 23 (47) 11 (44) 12 (50) .39

Dyslipidemia 32 (65) 16 (64) 16 (67) .50
Body composition, mean (SD)




Body weight (kg) 76.27 (14.29) 75.84 (15.52) 76.71 (13.19) .84

Body fat percentage 29.39 (5.51) 29.90 (5.93) 28.84 (5.11) .51

BMI 27.28 (4.29) 27.07 (4.46) 27.05 (4.19) .73

Basal metabolic rate 1638.29 (246.50) 1619.6 (271.51) 1657.75 (221.61) .59
Laboratory parameters, mean (SD)




Creatinine (mg/dL) 1.26 (0.40) 1.15 (0.34) 1.33 (0.44) .12

eGFRa (mL/min/1.73 m2) 66.53 (23.61) 73.03 (25.01) 64.27 (22.72) .21
CKDb stage, n (%)


.46

1 8 (16) 5 (20) 3 (13)

2 22 (45) 11 (44) 11 (46)

3a 11 (22) 7 (28) 4 (17)

3b 7 (14) 2 (8) 5 (21)

4 1 (2) 0 (0) 1 (4)

aeGFR: estimated glomerular filtration rate.

bCKD: chronic kidney disease.